SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is attracting significant attention as the community doubles down on its brand-building initiatives, ranging from IRL products like energy drinks and spices to community-led racing projects. Supporters are highlighting the project's consistent organic growth and active participation, with many emphasizing their conviction through daily accumulation and long-term holding.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

Fetch.ai is trending as investors aggressively accumulate on dips, driven by excitement over its infrastructure for autonomous AI agents and its integration into the broader Artificial Superintelligence Alliance. The community remains highly focused on potential long-term adoption and technical catalysts, with many participants actively discussing breakout price levels and debating strategic positioning amid broader market volatility.

Stellar is an open-source, decentralized network co-founded in 2014 by Jed McCaleb and Joyce Kim to facilitate the fast and low-cost transfer of value across different currencies and assets globally. Managed by the non-profit Stellar Development Foundation, the project serves as a global infrastructure that connects banks, payment systems, and individuals to expand financial access to underserved populations. Its main value proposition lies in providing a bridge between traditional money and digital networks through the use of Anchors, which are trusted entities that hold deposits and issue credits on the ledger.  The network operates using the Stellar Consensus Protocol and a Federated Byzantine Agreement, where nodes choose trusted sets of other nodes to agree on the state of the ledger. This system ensures high throughput and fast finality, where transactions are considered permanent and irreversible within seconds. Key features include a built-in distributed exchange for trading assets without intermediaries and the Soroban platform for developing smart contracts. Users can also utilize the network for tokenizing real-world assets or accessing decentralized finance services like peer-to-peer lending.  Stellar's native token, XLM, is essential for maintaining network integrity by acting as an intermediary to find efficient exchange paths and preventing spam through small transaction fees and minimum account balance requirements. Unlike many other digital assets, the network has no inflation because the community voted to disable the automatic creation of new tokens. While the project received early funding from the payments company Stripe, it is now sustained by a global community of validators and developers rather than traditional venture capital.

Stellar Lumens

Stellar Lumens is trending heavily as the community reacts to the DTCC's decision to utilize its blockchain for tokenizing traditional financial assets like stocks and government bonds. While some investors view this as a massive validation of Stellar's institutional utility, others are debating the sustainability of the price action, leading to intense discussions about potential short squeezes versus long-term valuation shifts.

KAIO provides institutional-grade real-world asset (RWA) tokenization infrastructure that seamlessly connects traditional investment funds with digital capital markets. Through its purpose-built protocol, KAIO enables leading global asset managers to issue and distribute regulated tokenized funds across multiple high-performance blockchain networks — including Ethereum, Sei, Hedera, Solana, Aptos, and others — significantly expanding global access to institutional-quality real-world asset strategies for qualified investors.   By tokenizing feeder structures and shares in flagship funds, KAIO brings onchain access to proven strategies such as the BlackRock ICS US Dollar Liquidity Fund (one of the world’s largest institutional money market funds), the Brevan Howard Master Fund, Hamilton Lane’s Senior Credit Opportunities Fund (SCOPE) via the HL SCOPE Access Fund, and Laser Digital’s Laser Carry Fund (LCF), among others. These tokenized vehicles deliver secure, compliant exposure to money market, macro, private credit, and alternative strategies while unlocking new levels of programmability, composability, and 24/7 liquidity in DeFi environments.

KAIO

KAIO is trending as the community debates its potential for a sharp reversal, with supporters highlighting its role in reducing access barriers to real-world assets. While some investors see it as an attractive accumulation opportunity, others are actively questioning its performance since launch and expressing skepticism regarding its immediate trajectory.

Tidal Trust II - YieldMax Gold Miners Option Income Strategy ETF

YieldMax Gold Miners Option Income Strategy ETF

GDXY is trending as investors debate the sustainability of its high weekly distributions against ongoing NAV erosion caused by the volatility of gold miners. While some in the community highlight gold as a vital hedge against debt and geopolitical uncertainty, others are frustrated by the downward price action and are choosing to rotate capital into other assets.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing increased volatility and investor scrutiny following news that Pfizer is offloading its stake in the company, signaling a potential shift in the broader outlook for mRNA-based partnerships. The community remains focused on the company's transition from a COVID-centric revenue model to a pipeline-heavy oncology strategy, with ongoing debate regarding the long-term clinical viability of its mRNA-based cancer therapies and recent clinical trial data readouts.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the project's long-term utility versus persistent price suppression, with the community split between those accumulating at lower levels and critics calling for accountability regarding development progress. Sentiment is heavily polarized, fueled by anticipation for regulatory clarity and lingering frustration over the token's inability to regain historical price levels.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Investors are flocking to PSLV as a preferred physical-backed alternative to paper silver, driven by concerns over COMEX inventory levels and the structural supply-demand deficit. The community remains heavily focused on potential price decoupling between physical silver and paper-based ETFs, with many viewing dips as strategic accumulation opportunities amidst ongoing inflationary pressures and geopolitical instability.

Gap, Inc. operates as a global apparel retail company, which offers clothing, apparel, accessories, and personal care products for men, women, and children. The firm operates through the following segments: Gap Global, Old Navy Global, Banana Republic Global, Athleta, and Other. The Gap Global segment includes apparel and accessories for men and women under the Gap brand, along with the GapKids, BabyGap, GapMaternity, GapBody, and GapFit collections. The Old Navy Global segment offers clothing and accessories for adults and children. The Banana Republic Global segment provides clothing, eyewear, jewelry, shoes, handbags, and fragrances. The Athleta segment offers fitness apparel for women. The company founded by Donald G. Fisher and Doris F. Fisher in July 1969 and is headquartered in San Francisco, CA.

Gap, Inc.

Gap, Inc. is trending as investors react to a lowered full-year sales outlook and a disappointing first-quarter revenue miss that overshadowed steady gross margins. The community is actively debating the impact of operational stumbles at Old Navy, the potential for a holiday season rebound, and whether current market sentiment has created an oversold buying opportunity.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is gaining significant momentum as institutional interest rises, marked by major capital inflows from fintech treasury strategies and progress toward staked ETFs. The community is actively leveraging this growth by accumulating the leading ecosystem meme, $NONJA.X, viewing it as a high-beta play that stands to benefit from Injective's strong DeFi infrastructure and deflationary tokenomics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Ligand Pharmaceuticals (NASDAQ:LGND) Insider Sells 5,000 Shares of Stock

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) insider Andrew Reardon sold 5,000 shares of the business's stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $231.31, for a total transaction of $1,156,550.00. Following the completion of the...

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS lessened its stake in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 33.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 60,342 shares of the biotechnology compan...

HC Wainwright Brokers Increase Earnings Estimates for LGND

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) - Stock analysts at HC Wainwright lifted their Q3 2026 earnings per share estimates for Ligand Pharmaceuticals in a research note...

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Rating of "Moderate Buy" from Analysts

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Get Free Report) has earned an average rating of "Moderate Buy" from the eight brokerages that are currently covering the company, Marketbeat...

HC Wainwright Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price

HC Wainwright boosted their target price on Ligand Pharmaceuticals from $243.00 to $289.00 and gave the company a "buy" rating in a research report on Thursday...

Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - Here's Why

Ligand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - What's Next...

Moody Aldrich Partners LLC Has $3.70 Million Stock Holdings in Ligand Pharmaceuticals Incorporated $LGND

Moody Aldrich Partners LLC decreased its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND - Free Report) by 24.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 19,581 shares of the biotechnology company's stock after selling 6,303 sha...

Royal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price

Royal Bank Of Canada lifted their price target on shares of Ligand Pharmaceuticals from $235.00 to $252.00 and gave the company an "outperform" rating in a research report on Tuesday...

Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook

Ligand Pharmaceuticals (NASDAQ:LGND) detailed plans to acquire XOMA Royalty Corporation in an investor call, outlining what executives described as a highly complementary transaction intended to...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation PR Newswire NEW YORK...

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.99	--	--	N/A
Q1 '26	$1.82	$1.63	-10.23%	MISSED
Q4 '25	$1.50	$2.02	34.92%	BEAT
Q3 '25	$1.93	$3.09	60.24%	BEAT
Q2 '25	$1.42	$1.60	12.56%	BEAT

LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q1 '26

Historical Earnings

Compact View

Latest LGND News

LGNDLigand Pharmaceuticals, Inc. - Ordinary Shares - Class B